SOLV
Solventum CorporationNYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
7.09
PEG
0.03
P/B
2.19
P/S
1.32
EV/EBITDA
5.40
DCF Value
$179.28
FCF Yield
-0.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.5%
Operating Margin
26.2%
Net Margin
18.7%
ROE
36.7%
ROA
25.9%
ROIC
17.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $2.00B | $63.0M | $0.37 |
| FY 2025 | $8.32B | $1.56B | $8.88 |
| Q3 2025 | $2.10B | $1.27B | $7.22 |
| Q2 2025 | $2.16B | $90.0M | $0.51 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.77
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.